BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quigg RJ. Complement and the kidney. J Immunol 2003;171:3319-24. [PMID: 14500622 DOI: 10.4049/jimmunol.171.7.3319] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Alpers CE, Kowalewska J. Emerging Paradigms in the Renal Pathology of Viral Diseases. CJASN 2007;2:S6-S12. [DOI: 10.2215/cjn.00280107] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
2 Høeg TB, Klein R, Moldow B, La Cour M, Klemp K, Erngaard D, Buch H, Ellervik C. THE ASSOCIATION BETWEEN CUTICULAR DRUSEN AND KIDNEY FUNCTION: A Population-Based Case-Control Study. Retina 2016;36:896-900. [PMID: 27115854 DOI: 10.1097/IAE.0000000000000808] [Reference Citation Analysis]
3 Rother RP, Mojcik CF, Mccroskery EW. Inhibition of terminal complement: a novel therapeutic approach for the treatment of systemic lupus erythematosus. Lupus 2004;13:328-34. [DOI: 10.1191/0961203303lu1021oa] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 8.0] [Reference Citation Analysis]
4 Bao L, Haas M, Minto AW, Quigg RJ. Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis. Lab Invest 2007;87:357-64. [PMID: 17259999 DOI: 10.1038/labinvest.3700522] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
5 Couser WG. Membranous Nephropathy: A Long Road but Well Traveled. JASN 2005;16:1184-7. [DOI: 10.1681/asn.2005010087] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
6 Würzner R, Zimmerhackl LB. Therapeutic strategies for atypical and recurrent hemolytic uremic syndromes (HUS). In: Zipfel PF, editor. Complement and Kidney Disease. Basel: Birkhäuser-Verlag; 2006. pp. 149-63. [DOI: 10.1007/3-7643-7428-4_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Abbate M, Zoja C, Corna D, Rottoli D, Zanchi C, Azzollini N, Tomasoni S, Berlingeri S, Noris M, Morigi M. Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury. J Am Soc Nephrol. 2008;19:1158-1167. [PMID: 18354030 DOI: 10.1681/asn.2007060686] [Cited by in Crossref: 54] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
8 Boyd AS, Wood KJ. Characteristics of the early immune response following transplantation of mouse ES cell derived insulin-producing cell clusters. PLoS One 2010;5:e10965. [PMID: 20532031 DOI: 10.1371/journal.pone.0010965] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
9 Takano T, Elimam H, Cybulsky AV. Complement-mediated cellular injury. Semin Nephrol. 2013;33:586-601. [PMID: 24161043 DOI: 10.1016/j.semnephrol.2013.08.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
10 Alexander JJ, Aneziokoro OG, Chang A, Hack BK, Markaryan A, Jacob A, Luo R, Thirman M, Haas M, Quigg RJ. Distinct and separable roles of the complement system in factor H-deficient bone marrow chimeric mice with immune complex disease. J Am Soc Nephrol 2006;17:1354-61. [PMID: 16597679 DOI: 10.1681/ASN.2006020138] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
11 Dimitrova P, Gyurkovska V, Shalova I, Saso L, Ivanovska N. Inhibition of zymosan-induced kidney dysfunction by tyrphostin AG-490. J Inflamm (Lond) 2009;6:13. [PMID: 19416544 DOI: 10.1186/1476-9255-6-13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
12 Vielhauer V, Stavrakis G, Mayadas TN. Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Invest. 2005;115:1199-1209. [PMID: 15841213 DOI: 10.1172/jci23348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 41] [Article Influence: 0.1] [Reference Citation Analysis]
13 Alexander JJ, Wang Y, Chang A, Jacob A, Minto AW, Karmegam M, Haas M, Quigg RJ. Mouse podocyte complement factor H: the functional analog to human complement receptor 1. J Am Soc Nephrol 2007;18:1157-66. [PMID: 17344423 DOI: 10.1681/ASN.2006101125] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
14 Zoja C, Abbate M, Remuzzi G. Progression of chronic kidney disease: insights from animal models. Curr Opin Nephrol Hypertens 2006;15:250-7. [PMID: 16609291 DOI: 10.1097/01.mnh.0000222691.53970.83] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
15 Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol. 2013;33:479-492. [PMID: 24161035 DOI: 10.1016/j.semnephrol.2013.08.001] [Cited by in Crossref: 350] [Cited by in F6Publishing: 309] [Article Influence: 43.8] [Reference Citation Analysis]
16 Suzuki T, Horita S, Kadoya K, Mitsuiki K, Aita K, Harada A, Nitta K, Nagata M. C4d Immunohistochemistry in glomerulonephritis with different antibodies. Clin Exp Nephrol 2007;11:287-91. [PMID: 18085389 DOI: 10.1007/s10157-007-0496-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wang Y, He Q, Qin H, Xu J, Tong J, Gao L, Xu J. The complement C5b-9 complexes induced injury of glomerular mesangial cells in rats with Thy-1 nephritis by increasing nitric oxide synthesis. Life Sciences 2006;79:182-92. [DOI: 10.1016/j.lfs.2005.12.053] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
18 Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006;17:1503-1520. [PMID: 16707563 DOI: 10.1681/asn.2006010017] [Cited by in Crossref: 673] [Cited by in F6Publishing: 304] [Article Influence: 42.1] [Reference Citation Analysis]
19 Bao L, Wang Y, Chen P, Sarav M, Haas M, Minto AW, Petkova M, Quigg RJ. Mesangial cell complement receptor 1-related protein y limits complement-dependent neutrophil accumulation in immune complex glomerulonephritis. Immunology 2009;128:e895-904. [PMID: 19740350 DOI: 10.1111/j.1365-2567.2009.03102.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Kitching AR. More Targeted Treatments for Lupus Nephritis: Is the Future (Nearly) Here? JASN 2005;16:3146-8. [DOI: 10.1681/asn.2005090900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Cybulsky AV, Quigg RJ, Salant DJ. Experimental membranous nephropathy redux. Am J Physiol Renal Physiol 2005;289:F660-71. [PMID: 16159900 DOI: 10.1152/ajprenal.00437.2004] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 4.6] [Reference Citation Analysis]
22 Smith KD, Alpers CE. Pathogenic mechanisms in membranoproliferative glomerulonephritis. Curr Opin Nephrol Hypertens 2005;14:396-403. [PMID: 15931011 DOI: 10.1097/01.mnh.0000172729.60122.f9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
23 Basile DP, Anderson MD, Sutton TA. Pathophysiology of acute kidney injury. Compr Physiol 2012;2:1303-53. [PMID: 23798302 DOI: 10.1002/cphy.c110041] [Cited by in Crossref: 165] [Cited by in F6Publishing: 302] [Article Influence: 18.3] [Reference Citation Analysis]
24 Qiu W, Che N, Feng X, Xia M, Wang H, Zhao D, Wang Y. Apoptosis of glomerular mesangial cells induced by sublytic C5b-9 complexes in rats with Thy-1 nephritis is dependent on Gadd45 gamma upregulation. Eur J Immunol 2009;39:3251-66. [PMID: 19882653 DOI: 10.1002/eji.200939264] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
25 Mella A, Messina M, Lavacca A, Biancone L. Complement cascade and kidney transplantation: The rediscovery of an ancient enemy. World J Transplant 2014; 4(3): 168-175 [PMID: 25346889 DOI: 10.5500/wjt.v4.i3.168] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
26 Wenderfer SE, Swinford RD, Braun MC. C1q nephropathy in the pediatric population: pathology and pathogenesis. Pediatr Nephrol 2010;25:1385-96. [PMID: 20180137 DOI: 10.1007/s00467-009-1429-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
27 Thurman JM, Holers VM. Complement deficient mice as model systems for kidney diseases. In: Zipfel PF, editor. Complement and Kidney Disease. Basel: Birkhäuser-Verlag; 2006. pp. 49-63. [DOI: 10.1007/3-7643-7428-4_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Alghadban S, Kenawy HI, Dudler T, Schwaeble WJ, Brunskill NJ. Absence of the Lectin Activation Pathway of Complement Ameliorates Proteinuria-Induced Renal Injury. Front Immunol 2019;10:2238. [PMID: 31608060 DOI: 10.3389/fimmu.2019.02238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Vielhauer V, Stavrakis G, Mayadas TN. Renal cell–expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Invest 2005;115:1199-209. [DOI: 10.1172/jci200523348] [Cited by in Crossref: 80] [Article Influence: 4.7] [Reference Citation Analysis]